IMPURITIES AVAILABLE FOR 'Fulvestrant'

Omsynth Lifesciences Pvt. Ltd. is one of the leading manufacturer and exporter of Fulvestrant. Fulvestrant is a selective estrogen receptor degrader (SERD) used primarily in the treatment of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer in postmenopausal women. It works by binding to estrogen receptors (ER) and promoting their degradation, effectively blocking estrogen signaling that drives tumor growth. Fulvestrant is administered via intramuscular injection, typically once a month, and is often used after progression on other hormone therapies like tamoxifen or aromatase inhibitors. It is effective as monotherapy or in combination with targeted agents such as CDK4/6 inhibitors. Common side effects include injection site pain, fatigue, hot flashes, joint pain, and nausea. Unlike some hormonal therapies, fulvestrant does not have estrogen-like effects on other tissues. Regular monitoring is recommended to assess treatment response and manage potential adverse effects. Buy high quality Fulvestrant from Omsynth Lifesciences.